CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE710.55-9.75 (-1.35 %)
PREV CLOSE () 720.30
OPEN PRICE () 725.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 638226
TODAY'S LOW / HIGH ()700.90 734.00
52 WK LOW / HIGH ()356.75 734
NSE710.40-9.75 (-1.35 %)
PREV CLOSE() 720.15
OPEN PRICE () 724.00
BID PRICE (QTY) 710.40 (461)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12500684
TODAY'S LOW / HIGH() 701.00 734.20
52 WK LOW / HIGH ()355.3 734.2
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrar's Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
27Jul Cipla, Precision Camshafts and Jenburk
Cipla has been granted regulatory approval by the Drug Controller Genera..
27Jul Cipla gains on getting DCGI’s nod to l
Cipla is currently trading at Rs. 669.10, up by 3.60 points or 0.54% fro..
25Jul Cipla gets DCGI’s nod to launch Ciplen
Cipla has been granted regulatory approval by the Drug Controller Genera..
24Jul Cipla all set to launch Favipiravir
Cipla is all set to launch Favipiravir, developed by the Council of Scie..
20Jul Cipla, Amgen settle case involving gen
Cipla has reached a settlement with Amgen Inc on pending litigation invo..
Financials
in Millions
QTR Mar 20 ANNUAL 20
Net Profit6045.723181.7
Gross Profit 7085.5 29643.1
Operating Profit 8782.136001.4
Net Sales 31334.4126591.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8306.40 (6.85%)
M.Cap ( in Cr)
19130.16
Abbott India (BSE)
 15996.95 (2.73%)
M.Cap ( in Cr)
33992.40
Procter&Gamble Healt (BSE)
 4402.10 (5.70%)
M.Cap ( in Cr)
7307.21
Solara Active Pharma (BSE)
 908.80 (18.98%)
M.Cap ( in Cr)
2440.61
Pfizer (BSE)
 4397.65 (2.95%)
M.Cap ( in Cr)
20118.25
Shareholding Pattern
PROMOTERS 36.68%
NON-INSTITUTION 23.4%
MUTUAL FUNDS/UTI 16.29%
FI/BANKS/INSURANCE 4.78%
FII 0.01%
GOVERNMENT 0%
attention investors

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day....issued in the interest of investors.

Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/Subscribe for sms alerts /email ids with your stock brokers. receive information of your transactions directly from exchange/depository on your mobile/email at the end of the day.......... issued in the interest of investors | KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, dp, mutual fund etc.), you need not undergo the same process again when you approach another intermediary.

Copyright © 2017 ExcelStock Broking Pvt. Ltd. All Rights Reserved
Designed , Developed & Content Powered by  Accord Fintech Pvt. Ltd.
close X

Download Client Registration Documents